Trigeminal neurons control immune-bone cell interaction and metabolism in apical periodontitis
Apical periodontitis (AP) is an inflammatory disease occurring following tooth infection with distinct osteolytic activity. Despite increasing evidence that sensory neurons participate in regulation of non-neuronal cells, their role in the development of AP is largely unknown. We hypothesized that t...
Gespeichert in:
Veröffentlicht in: | Cellular and molecular life sciences : CMLS 2022-06, Vol.79 (6), p.330-330, Article 330 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Apical periodontitis (AP) is an inflammatory disease occurring following tooth infection with distinct osteolytic activity. Despite increasing evidence that sensory neurons participate in regulation of non-neuronal cells, their role in the development of AP is largely unknown. We hypothesized that trigeminal ganglia (TG) Nav1.8
+
nociceptors regulate bone metabolism changes in response to AP. A selective ablation of nociceptive neurons in Nav1.8
Cre
/Diphtheria toxin A (DTA)
Lox
mouse line was used to evaluate the development and progression of AP using murine model of infection-induced AP. Ablation of Nav1.8
+
nociceptors had earlier progression of AP with larger osteolytic lesions. Immunohistochemical and RNAscope analyses demonstrated greater number of macrophages, T-cells, osteoclast and osteoblast precursors and an increased RANKL:OPG ratio at earlier time points among Nav1.8
Cre
/ DTA
Lox
mice. There was an increased expression of IL-1α and IL-6 within lesions of nociceptor-ablated mice. Further, co-culture experiments demonstrated that TG neurons promoted osteoblast mineralization and inhibited osteoclastic function. The findings suggest that TG Nav1.8
+
neurons contribute to modulation of the AP development by delaying the influx of immune cells, promoting osteoblastic differentiation, and decreasing osteoclastic activities. This newly uncovered mechanism could become a therapeutic strategy for the treatment of AP and minimize the persistence of osteolytic lesions in refractory cases.
Graphical abstract |
---|---|
ISSN: | 1420-682X 1420-9071 |
DOI: | 10.1007/s00018-022-04335-w |